Clinical characteristics and outcomes of invasive pneumococcal disease in neonates: A retrospective study
Turkish Journal of Pediatric Disease · 20.01.2026 · 20 (1) · 58-63
DOI: 10.12956/tjpd.2025.1217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Pediatric Disease, online erschienen am 20.01.2026. Verfasst von Büşra Demirci und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Invasive pneumococcal disease (IPD) is a rare but serious cause of neonatal sepsis associated with significant morbidity and mortality. Despite widespread pneumococcal conjugate vaccine (PCV) use in infants, neonates remain vulnerable due to lack of direct vaccination and potential vertical or horizontal transmission. This study aimed to characterize the clinical, laboratory, and microbiological features of neonatal IPD and to evaluate associated outcomes in this high-risk population. Material and Methods: We conducted a retrospective cross-sectional study of neonates (0–30 days old) diagnosed with IPD between September 2019 and April 2025. Diagnosis was confirmed by isolation of Streptococcus pneumoniae from sterile body fluids or PCR detection. Demographic, clinical, microbiological, and outcome data were analyzed.
Results
Among 68 IPD cases, 12 neonates with pneumococcal bacteremia were identified; no meningitis or focal infections were observed. The cohort had equal sex distribution, mean gestational age of 35±3.8 weeks, and 33.3% had comorbidities. Early-onset sepsis (≤72 hours) accounted for 25% of cases, with the remainder presenting as late-onset sepsis (>72 hours). One neonate had concurrent SARS-CoV-2 infection. All patients survived; one preterm infant developed neurological sequelae attributable to pre-existing conditions. Antibiotic susceptibility testing showed reduced sensitivity to penicillin (20%) and ceftriaxone (16.7%), while vancomycin and linezolid remained highly effective.
Conclusion
Neonatal invasive pneumococcal bacteremia, although uncommon, continues to pose clinical challenges, particularly due to evolving antimicrobial resistance. Our findings emphasize the importance of vigilant clinical monitoring and tailored antimicrobial therapy in this vulnerable population. Continued surveillance and prospective studies are warranted to assess the impact of maternal and early infant vaccination strategies on neonatal IPD prevention.
Zitieren
APA
Demirci, B., Bayhan, G. İ., Erat, T., Yahşi, A., Özen, S., Baş, A. Y., Çetin, D., Dinç, B., & Oğuz, Ş. S. (2026). Clinical characteristics and outcomes of invasive pneumococcal disease in neonates: A retrospective study. Turkish Journal of Pediatric Disease, 20(1), 58-63. https://doi.org/10.12956/tjpd.2025.1217
Vancouver
Demirci B, Bayhan Gİ, Erat T, Yahşi A, Özen S, Baş AY, et al. Clinical characteristics and outcomes of invasive pneumococcal disease in neonates: A retrospective study. Turkish Journal of Pediatric Disease. 2026;20(1):58-63. doi:10.12956/tjpd.2025.1217
BibTeX
@article{Demirci2026,
author = {Demirci, Büşra and Bayhan, Gülsüm İclal and Erat, Tuğba and Yahşi, Aysun and Özen, Seval and Baş, Ahmet Yağmur and Çetin, Dilek and Dinç, Bedia and Oğuz, Şerife Suna},
title = {Clinical characteristics and outcomes of invasive pneumococcal disease in neonates: A retrospective study},
journal = {Turkish Journal of Pediatric Disease},
year = {2026},
volume = {20},
number = {1},
pages = {58--63},
doi = {10.12956/tjpd.2025.1217}
}
EUVIMED